Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) insider Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $23.66, for a total value of $283,920.00. Following the completion of the sale, the insider now owns 1,053,313 shares of the […]
Apellis Pharmaceuticals (NASDAQ:APLS) Rating Lowered to Neutral at JPMorgan Chase & Co theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Bank of America cut shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Tuesday morning, Marketbeat Ratings reports. They currently have $40.00 target price on the stock, down from their previous target price of $114.00. APLS has been the subject […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price objective reduced by Raymond James from $156.00 to $89.00 in a research note issued to investors on Tuesday, Benzinga reports. Raymond James currently has a strong-buy rating on the stock. Other equities analysts have also issued research reports about the stock. Citigroup dropped their price target […]
Apellis Pharmaceuticals (APLS) to Release Earnings on Monday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.